Phentermine and Lorazepam: Safety Concerns for Concurrent Use
Concurrent use of phentermine and lorazepam is not recommended due to the significant risk of central nervous system depression, respiratory depression, and potentially fatal outcomes. 1
Mechanism of Concern
- Benzodiazepines (like lorazepam) and stimulants (like phentermine) have opposing effects on the central nervous system, creating unpredictable physiological responses 1
- Phentermine is a sympathomimetic amine anorectic that stimulates the central nervous system, increasing blood pressure and heart rate 1
- Lorazepam is a benzodiazepine that causes central nervous system depression and can decrease respiratory drive 1
- This combination can lead to dangerous fluctuations in vital signs and neurological status 1
Specific Risks
- Increased risk of potentially fatal overdose when benzodiazepines are combined with other central nervous system active medications 1
- Case-cohort studies have found concurrent benzodiazepine use with other controlled substances to be associated with a near quadrupling of risk for overdose death 1
- Phentermine may reduce the sedative effects of lorazepam, potentially leading to unpredictable clinical responses 2
- The combination may increase the risk of cardiovascular side effects, including arrhythmias 3
Clinical Guidance
- Avoid prescribing phentermine and lorazepam concurrently whenever possible 1
- If a patient is already on benzodiazepine therapy and requires weight management:
- If a patient on phentermine requires treatment for anxiety:
Special Considerations
- Patients with a history of substance use disorders are at particularly high risk with this combination 1
- Patients with cardiovascular disease, hypertension, or psychiatric disorders should avoid this combination due to increased risks 1, 2
- If both medications are absolutely necessary (which is rare), consider:
Common Pitfalls
- Assuming that because one medication is for weight loss and another for anxiety, they won't interact significantly 2
- Failing to check prescription drug monitoring programs for concurrent controlled medications prescribed by other clinicians 1
- Not recognizing that fatalities have been reported with concurrent use of benzodiazepines with other central nervous system active medications 1
- Underestimating the additive adverse effects when these medications are combined 3